Where Are We?  Where Are We Going?  Assessing the State of Myeloma: Register Now for the Myeloma Crowd Round Table Webcast on September 25

Where Are We? Where Are We Going? Assessing the State of Myeloma: Register Now for the Myeloma Crowd Round Table Webcast on September 25

September 25 @ 12:30pm — 2:00pm EDT

Two World-Recognized Experts Reflect on the State of Myeloma Treatment and Research

When first confronted with a myeloma diagnosis, it is difficult to see the big picture about a disease you’ve likely never heard of before.  “What do I do NOW?” is a normal reaction.

But looking into the myeloma universe, this is a fairly optimistic time for myeloma specialists and the majority of patients.  Survival rates are longer than ever and getting longer.  Side effects are increasingly better understood, managed and avoided.

And the word “cure” is no longer a taboo word in polite company.  Yet great challenges remain, especially for those with high-risk disease.

Drs. Rafael Fonseca, from the Mayo Clinic, and Ola Landgren, formerly from Memorial Sloan-Kettering Cancer Center and now with the University of Miami, have strong opinions.  They have been key thought leaders in myeloma for years—as researchers, researchers, and active clinicians treating thousands of patients.

In this, the 21st and final webcast before we restart in-person meetings—which will be broadcast live over the internet and archived—Jenny Ahlstrom, founder and president of the HealthTree Foundation, will engage in a far-reaching discussion with Drs. Fonseca and Landgren about where their field is, where it has been, and where it is going.

Please join us on Saturday, September 25 for a 90 minute program, beginning at 12:30 pm Eastern Daylight Time (9:30 am Pacific, 10:30 am Mountain, 11:30 am Central, 17:30 GMT, 18:30 CET).

If you have any questions, please contact Greg Brozeit at greg@healthtree.org or call 330-990-1090.

Schedule & Agenda

September 25 @ 12:30pm — 2:00pm EDT

12:30pm

Jennifer Ahlstrom

Where Are We? Where Are We Going? Assessing the State of Myeloma

Welcome and Introduction

12:35pm

Full Faculty

Where Are We? Where Are We Going? Assessing the State of Myeloma

Jennifer Ahlstrom discuss the state of myeloma today with:

Rafael Fonseca, MD, Mayo Clinic

C. Ola Landgren, MD, PhD, Sylvester Cancer Center, University of Miami

1:20pm

Full Faculty

Where Are We? Where Are We Going? Assessing the State of Myeloma

Audience Questions and Answers

Speakers & Moderators

Jennifer Ahlstrom

Jenny A - Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials...

Read Bio

Greg Brozeit

Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the...

Read Bio

Rafael Fonseca, MD

Rafael Fonseca, MD, is the Getz Family Professor of Cancer, Professor of Medicine, interim Executive Director of the Mayo Clinic Comprehensive Cancer Center, Director for Innovatio...

Read Bio

C. Ola Landgren, MD, PhD

C. Ola Landgren, MD, PhD, is Professor of Medicine, Chief of the Myeloma Program, and Leader of the Experimental Program at the University of Miami Sylvester Cancer Center. Read m...

Read Bio

About Myeloma Crowd Round Tables (MCRTs)

About Myeloma Crowd Round Tables (MCRTs)

Myeloma Crowd Round Tables (MCRTs) are education programs for myeloma patients and caregivers on a variety of treatment and research issues.  Each MCRT features presentations from internationally-recognized myeloma experts who also take extensive Q&A sessions from audience members.

Register Today!

September 25 @ 12:30pm — 2:00pm EDT

Event Sponsors





Thanks to our Myeloma Crowd Community sponsors:

.                         .